174 related articles for article (PubMed ID: 37083973)
1. Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma.
She Z; Marzullo A; Destito M; Spadea MF; Leone R; Anzalone N; Steffanoni S; Erbella F; Ferreri AJM; Ferrigno G; Calimeri T; De Momi E
Int J Comput Assist Radiol Surg; 2023 Oct; 18(10):1849-1856. PubMed ID: 37083973
[TBL] [Abstract][Full Text] [Related]
2. Interpreting deep learning models for glioma survival classification using visualization and textual explanations.
Osadebey M; Liu Q; Fuster-Garcia E; Emblem KE
BMC Med Inform Decis Mak; 2023 Oct; 23(1):225. PubMed ID: 37853371
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
4. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
5. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
Nguyen AV; Blears EE; Ross E; Lall RR; Ortega-Barnett J
Neurosurg Focus; 2018 Nov; 45(5):E5. PubMed ID: 30453459
[TBL] [Abstract][Full Text] [Related]
6. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
7. Deep Learning for Automatic Differential Diagnosis of Primary Central Nervous System Lymphoma and Glioblastoma: Multi-Parametric Magnetic Resonance Imaging Based Convolutional Neural Network Model.
Xia W; Hu B; Li H; Shi W; Tang Y; Yu Y; Geng C; Wu Q; Yang L; Yu Z; Geng D; Li Y
J Magn Reson Imaging; 2021 Sep; 54(3):880-887. PubMed ID: 33694250
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
9. Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients.
Destito M; Marzullo A; Leone R; Zaffino P; Steffanoni S; Erbella F; Calimeri F; Anzalone N; De Momi E; Ferreri AJM; Calimeri T; Spadea MF
Bioengineering (Basel); 2023 Feb; 10(3):. PubMed ID: 36978676
[TBL] [Abstract][Full Text] [Related]
10. Radiomic-Based MRI for Classification of Solitary Brain Metastases Subtypes From Primary Lymphoma of the Central Nervous System.
Zhao LM; Hu R; Xie FF; Clay Kargilis D; Imami M; Yang S; Guo JQ; Jiao X; Chen RT; Wei-Hua L; Li L
J Magn Reson Imaging; 2023 Jan; 57(1):227-235. PubMed ID: 35652509
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
Xia W; Hu B; Li H; Geng C; Wu Q; Yang L; Yin B; Gao X; Li Y; Geng D
J Magn Reson Imaging; 2021 Jan; 53(1):242-250. PubMed ID: 32864825
[TBL] [Abstract][Full Text] [Related]
13. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques.
Bathla G; Priya S; Liu Y; Ward C; Le NH; Soni N; Maheshwarappa RP; Monga V; Zhang H; Sonka M
Eur Radiol; 2021 Nov; 31(11):8703-8713. PubMed ID: 33890149
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival duration.
Huntoon K; Makary MS; Shah VS; Aquino A; Pandya V; Giglio P; Slone HW; Elder JB
Neuroradiol J; 2023 Aug; 36(4):479-485. PubMed ID: 36715098
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
Hatzoglou V; Oh JH; Buck O; Lin X; Lee M; Shukla-Dave A; Young RJ; Peck KK; Vachha B; Holodny AI; Grommes C
J Neurooncol; 2018 Nov; 140(2):351-358. PubMed ID: 30073640
[TBL] [Abstract][Full Text] [Related]
16. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
[TBL] [Abstract][Full Text] [Related]
17. Improving the Classification of PCNSL and Brain Metastases by Developing a Machine Learning Model Based on
Cui C; Yao X; Xu L; Chao Y; Hu Y; Zhao S; Hu Y; Zhang J
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983721
[No Abstract] [Full Text] [Related]
18. New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact.
Blasel S; Vorwerk R; Kiyose M; Mittelbronn M; Brunnberg U; Ackermann H; Voss M; Harter PN; Hattingen E
J Neurol; 2018 Mar; 265(3):647-658. PubMed ID: 29383512
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning-based Texture Analysis of Contrast-enhanced MR Imaging to Differentiate between Glioblastoma and Primary Central Nervous System Lymphoma.
Kunimatsu A; Kunimatsu N; Yasaka K; Akai H; Kamiya K; Watadani T; Mori H; Abe O
Magn Reson Med Sci; 2019 Jan; 18(1):44-52. PubMed ID: 29769456
[TBL] [Abstract][Full Text] [Related]
20. Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
Meling TR; Latysheva A; Da Broi M; Jahr G; Holte H; Beiske K; Emblem KE
Neuroradiology; 2018 Jul; 60(7):703-713. PubMed ID: 29804159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
